Literature DB >> 24604328

Association of DNA repair and cell cycle gene variations with breast cancer risk in Northeast Indian population: a multiple interaction analysis.

Mishi Kaushal Wasson1, Pradeep Singh Chauhan, L C Singh, Dheeraj Katara, Jagannath Dev Sharma, Eric Zomawia, Amal Kataki, Sujala Kapur, Sunita Saxena.   

Abstract

Polymorphisms in DNA repair and cell cycle genes contribute to increased breast cancer (BC) risk. Their association and interaction in relation to betel quid and tobacco chewing habits need exhaustive multi-analytical investigation to explain BC predisposition due to DNA damage. Polymorphism in TP53-72Arg>Pro, RAD51-135G>C, BRCA2, and CCND1-G870A were examined in 204 BC cases and 217 controls from Northeast Indian population. Multifaceted analytic approaches were used to explore relationships between polymorphisms, tobacco history, and BC susceptibility. Betel quid chewing was identified as the predominant risk factor. CCND-AA and dominant model showed protection towards BC in betel quid chewer (BQC) [(0.28 (0.10-0.77), 0.01 and 0.32 (0.12-0.81), 0.01)] and non-betel quid chewers (NBQC) [(0.26 (0.09-0.78), 0.01 and 0.37 (0.16-0.87), 0.02)]. TP53-Pro/Pro genotype showed protection towards BC in NBQC (0.29 (0.10-0.81), p=0.01) and (0.51 (0.32-0.80), p=0.003, respectively). RAD51-C allele was associated with BC risk (2.03 (1.26-3.30) 0.002) in BQC. Two BQC cases had BRCA2 8415G>T:K2729N mutation in Exon18. MDR analysis showed best four locus model with TBA 0.6765 (0.005) and CVC of 10/10 in NBQC. Interaction diagram concurred the interactions between TP53 and RAD51 (1.32 %) with independent effect (1.89 %) of CCND1in NBQC. In CART analysis, BQC with CCND1 GG genotype were at risk (OR=33.0; 95 % CI=6.08-179.07), p<0.001) followed by combination of BQC, CCND1, No-Smk, and Alc (OR=42.00; 95 % CI=5.11-345.11, p<0.001). Risk was also observed in BQC, CCND1, No-Smk, Non-Alc, and TP53 combination (OR=14.84; 95 % CI=3.13-70.34, p<0.001) and BQC, CCND1, No-Smk, Non-Alc, TP53 (OR=9.40; 95 % CI=1.99-44.34, p<0.001). NBQC group showed risk with combination of NBQC and TP53 (OR=5.54; 95 % CI=1.11-27.42, p=0.03). Genetic variants in DNA repair and cell cycle genes contribute to BC risk through gene-gene and gene-environmental interactions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24604328     DOI: 10.1007/s13277-014-1779-2

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  35 in total

1.  Interactions among genetic variants in apoptosis pathway genes, reflux symptoms, body mass index, and smoking indicate two distinct etiologic patterns of esophageal adenocarcinoma.

Authors:  Rihong Zhai; Feng Chen; Geoffrey Liu; Li Su; Matthew H Kulke; Kofi Asomaning; Xihong Lin; Rebecca S Heist; Norman S Nishioka; Chau-Chyun Sheu; John C Wain; David C Christiani
Journal:  J Clin Oncol       Date:  2010-04-12       Impact factor: 44.544

2.  CYCLIN D1 as a genetic modifier in hereditary nonpolyposis colorectal cancer.

Authors:  S Bala; P Peltomäki
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

3.  Association of the A870G cyclin D1 gene polymorphism with genetic susceptibility to nasopharyngeal carcinoma.

Authors:  Raquel J Catarino; Eduardo Breda; Vânia Coelho; Daniela Pinto; Hugo Sousa; Carlos Lopes; Rui Medeiros
Journal:  Head Neck       Date:  2006-07       Impact factor: 3.147

4.  Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer.

Authors:  Timothy R Porter; Frances M Richards; Richard S Houlston; D Gareth R Evans; Janusz A Jankowski; Fiona Macdonald; Gail Norbury; Stewart J Payne; Samantha A Fisher; Ian Tomlinson; Eamonn R Maher
Journal:  Oncogene       Date:  2002-03-14       Impact factor: 9.867

5.  CCND1 G870A polymorphism contributes to breast cancer susceptibility: a meta-analysis.

Authors:  Cheng Lu; Jing Dong; Hongxia Ma; Guangfu Jin; Zhibin Hu; Yuzhu Peng; Xirong Guo; Xinru Wang; Hongbing Shen
Journal:  Breast Cancer Res Treat       Date:  2008-09-26       Impact factor: 4.872

6.  Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck.

Authors:  C Matthias; K Branigan; V Jahnke; K Leder; J Haas; J Heighway; P W Jones; R C Strange; A A Fryer; P R Hoban
Journal:  Clin Cancer Res       Date:  1998-10       Impact factor: 12.531

7.  Polymorphisms in genes involved in homologous recombination repair interact to increase the risk of developing acute myeloid leukemia.

Authors:  Claire Seedhouse; Rowena Faulkner; Nadia Ashraf; Emma Das-Gupta; Nigel Russell
Journal:  Clin Cancer Res       Date:  2004-04-15       Impact factor: 12.531

8.  Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption.

Authors:  Joke Werbrouck; Kim De Ruyck; Fréderic Duprez; Marc Van Eijkeren; Ernst Rietzschel; Sofie Bekaert; Anne Vral; Wilfried De Neve; Hubert Thierens
Journal:  Mutat Res       Date:  2008-08-13       Impact factor: 2.433

9.  Contribution of germ line BRCA2 sequence alterations to risk of familial esophageal cancer in a high-risk area of India.

Authors:  M Kaushal; I Chattopadhyay; R Phukan; J Purkayastha; J Mahanta; S Kapur; S Saxena
Journal:  Dis Esophagus       Date:  2009-05-15       Impact factor: 3.429

10.  Trp53-dependent DNA-repair is affected by the codon 72 polymorphism.

Authors:  M Siddique; K Sabapathy
Journal:  Oncogene       Date:  2006-02-06       Impact factor: 9.867

View more
  7 in total

1.  MiRNA-binding site functional polymorphisms in DNA repair genes RAD51, RAD52, and XRCC2 and breast cancer risk in Chinese population.

Authors:  Jingjing Cao; Chenglin Luo; Rui Peng; Qiaoyun Guo; Kaijuan Wang; Peng Wang; Hua Ye; Chunhua Song
Journal:  Tumour Biol       Date:  2016-10-10

2.  Association of CCND1 Gene c.870G>A Polymorphism with Breast Cancer Risk: A Case-ControlStudy and a Meta-Analysis.

Authors:  Zahra Soleimani; Davood Kheirkhah; Mohammad Reza Sharif; Alireza Sharif; Mohammad Karimian; Younes Aftabi
Journal:  Pathol Oncol Res       Date:  2016-12-21       Impact factor: 3.201

Review 3.  A comprehensive analysis of BRCA2 gene: focus on mechanistic aspects of its functions, spectrum of deleterious mutations, and therapeutic strategies targeting BRCA2-deficient tumors.

Authors:  Anjali Shailani; Raman Preet Kaur; Anjana Munshi
Journal:  Med Oncol       Date:  2018-01-31       Impact factor: 3.064

4.  RAD51 135G>C substitution increases breast cancer risk in an ethnic-specific manner: a meta-analysis on 21,236 cases and 19,407 controls.

Authors:  Deepa Sekhar; Singh Pooja; Sandeep Kumar; Singh Rajender
Journal:  Sci Rep       Date:  2015-06-25       Impact factor: 4.379

5.  Medical genetics and genomic medicine in India: current status and opportunities ahead.

Authors:  Shagun Aggarwal; Shubha R Phadke
Journal:  Mol Genet Genomic Med       Date:  2015-05       Impact factor: 2.183

6.  DNA Repair Mechanism Gene, XRCC1A ( Arg194Trp) but not XRCC3 ( Thr241Met) Polymorphism Increased the Risk of Breast Cancer in Premenopausal Females: A Case-Control Study in Northeastern Region of India.

Authors:  K Rekha Devi; Jishan Ahmed; Kanwar Narain; Kaustab Mukherjee; Gautam Majumdar; Saia Chenkual; Jason C Zonunmawia
Journal:  Technol Cancer Res Treat       Date:  2017-11-21

7.  Association between Cyclin D1 G870A (rs9344) polymorphism and cancer risk in Indian population: meta-analysis and trial sequential analysis.

Authors:  Nisha Thakur; Suchitra Kumari; Ravi Mehrotra
Journal:  Biosci Rep       Date:  2018-11-30       Impact factor: 3.840

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.